Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21(ras) leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A(2) (PLA(2)), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)-stimulated cytosolic PLA(2) (cPLA(2)) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF-R) through a glucocorticoid receptor (GR)-dependent (RU486-sensitive), transcription-independent (actinomycin-insensitive), mechanism. The dexamethasone-induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co-localized with EGF-R. Like dexamethasone, peptides containing E-Q-E-Y-V from the N-terminal domain of LC1 also blocked ligand-induced association of Grb2, p21(ras) and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF-R
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [38]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [38]
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849 · cited 1×
“Activated Erk phosphorylates speci®c serine (Ser) residues within cytosolic phospholipase A2 (cPLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA) (Lin et al., 1993).”
BackgroundDNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“A recent study, for example, showed that, in contrast to the lethal nature of a GR knock-out, mice bearing a mutation of the GR which disabled dimerization, and hence GRE binding, survived (Reichardt et al., 1998).”
ResultTyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959 · cited 1×
“Moreover, direct regulation of signalling mechanisms also appears to be a feature of the action of other steroid receptors, such as that for oestradiol (Migliaccio et al., 1996), and other nuclear hormone receptors (Bost et al., 1997).”
BackgroundMolecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889 · cited 1×
“The unactivated (unligated) GR is retained in the cytoplasm as a multi-protein complex consisting of heat shock proteins (hsp) (Bamberger et al., 1996) and several kinases of the MAPK signalling system, including Src (Pratt, 1998).”
BackgroundHeck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522 · cited 1×
“The inference was that other transcriptional activators such as AP1 and NFkB, which are probably bound by the GR monomer (Heck et al., 1994), play a key role in mediating the action of glucocorticoids.”
BackgroundMultiple components in an epidermal growth factor-stimulated protein kinase cascade
Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64310-1 · Cited by 492
Pratt, W. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44252 · Cited by 447 · cited 12×
“We show here that both GR and Src are rapidly released from the hsp90 complex in A549 cells following treatment by dexamethasone.”
BackgroundInfluentialInvolvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387 · cited 1×
“…adapter protein Grb2 and the small GTPase p21ras initiates transduction of the mitogenic signalling mechanisms leading to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk) (Ahn et al., 1991; de Vries-Smits et al., 1992).”
BackgroundNuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334 · cited 1×
“Recently, other groups have implicated Jnk as an important mediator in A549 cell proliferation (Bost et al., 1997) and suggested that there is cross-talk between this pathway and activation of nuclear hormone receptors (Caelles et al., 1997).”
BackgroundEpidermal growth factor-dependent phosphorylation of lipocortin
Pepinsky, R. B., & Sinclair, L. K. (1986) · Nature · doi:10.1038/321081a0 · Cited by 301 · cited 1×
“…equally in vitro (Summers & Creutz, 1985; Schlaepfer & Haigler, 1988), and for PTK. LC1 is a low (50 nM) km substrate for the EGF-R in A431 cells (Pepinsky & Sinclair, 1986) and in ®broblasts and is also a substrate for the insulin receptor kinase in rat liver (Karasik et al., 1988), and…”
BackgroundRadke, K., & Martin, G. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5212 · Cited by 278 · cited 1×
“Extending this concept to other members of the annexin family, we may perhaps anticipate that LC2, as a substrate for pp60v-src oncogene kinases (Radke & Martin, 1979) as well as the insulin receptor kinase (Karasik et al., 1988), will have an analogous e ect on other src-dependent signalling…”
Whitesell, L. (1996) · Molecular Endocrinology · doi:10.1210/me.10.6.705 · Cited by 263 · cited 2×
“Geldanamycin is a benzoquinone ansamycin that selectively binds hsp90 and disrupts GR function (Whitesell & Cook, 1996) by preventing its nuclear translocation (Galigniana et al., 1998).”
BackgroundBuday, L., Egan, S. E., Rodriguez Viciana, P., Cantrell, D. A., & Downward, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37070-9 · Cited by 238 · cited 1×
“…that the inhibitory actions of LC1 are highly speci®c. Interestingly, several groups have described the presence of 36 ± 38 kDa Tyr-phosphorylated proteins that participate in the EGF-R control of p21ras activity (Buday et al., 1994) or other signal transduction systems (Fukazawa et al., 1995).”
BackgroundCharacterization of Ca2+-dependent phospholipid binding and phosphorylation of lipocortin I.
Schlaepfer, D. D., & Haigler, H. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48333-0 · Cited by 235 · cited 1×
“Both EGF-R and insulin receptor kinases phosphorylate LC1 Tyr21 (Tyr26 in LC2) exclusively (Karasik et al., 1988; Schlaepfer & Haigler, 1987).”
BackgroundDexamethasone Rapidly Induces a Novel Ras Superfamily Member-related Gene in AtT-20 Cells
Kemppainen, R. J., & Behrend, E. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3129 · Cited by 179 · cited 1×
“For example, the activity of p21ras is modulated by regulatory proteins such as GEFs and GAPs and may be inhibited by glucocorticoid-induced proteins such as Dexras1 (Kemppanien & Behrend, 1998) or the negative regulatory 66 kDa isoform of Shc (Okada et al., 1997).”
BackgroundGaligniana, M. D. (1998) · Molecular Endocrinology · doi:10.1210/me.12.12.1903 · Cited by 175 · cited 2×
“Geldanamycin is a benzoquinone ansamycin that selectively binds hsp90 and disrupts GR function (Whitesell & Cook, 1996) by preventing its nuclear translocation (Galigniana et al., 1998).”
BackgroundBost, F., McKay, R., Dean, N., & Mercola, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33422 · Cited by 171 · cited 2×
“Recently, other groups have implicated Jnk as an important mediator in A549 cell proliferation (Bost et al., 1997) and suggested that there is cross-talk between this pathway and activation of nuclear hormone receptors (Caelles et al., 1997).”
BackgroundDalman, F. C., Scherrer, L. C., Taylor, L. P., Akil, H., & Pratt, W. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67821-x · Cited by 163 · cited 3×
“Transient transfection of A549 cells with antisense LC1 cDNA oligonucleotides blocked the de novo synthesis of LC1, increased the amount of prostaglandins and AA released and lead to an increase in cell growth (Croxtall & Flower, 1994).”
BackgroundHuang, X., Li, Y., Tanaka, K., Moore, K. G., & Hayashi, J. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11618 · Cited by 158 · cited 1×
“These proteins are probably members of the lnk family (Huang et al., 1995): although they do not seem to be related to the annexins it is noteworthy that they also contain the sequence E-Y-V-X-T found in the biologically active peptides derived from LC1 (Croxtall et al., 1998).”
BackgroundLipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.
Croxtall, J. D., & Flower, R. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3571 · Cited by 139 · cited 3×
“In A549 cells, speci®c anti-LC1 neutralizing monoclonal antibodies readily reverse (Croxtall & Flower, 1992) ± while the addition of human recombinant LC1 or the N-terminal peptide LC113± 25 mimics ± the e ect of dexamethasone (Croxtall et al., 1998).”
BackgroundResultSelf-citationOkada, S., Kao, A. W., Ceresa, B. P., Blaikie, P., Margolis, B., & Pessin, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28042 · Cited by 134 · cited 2×
“The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogenactivated protein kinase pathway.”
BackgroundRAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2.
Jelinek, T., Catling, A. D., Reuter, C. W., Moodie, S. A., Wolfman, A., & Weber, M. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8212 · Cited by 119
SH2 and SH3 domains: Potential targets for anti-cancer drug design
Smithgall, T. E. (1995) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(95)00082-7 · Cited by 99 · cited 1×
“Blocking the interaction between Tyr-phosphorylated PTK receptors and Grb2 is considered by some to be an attractive strategy for inhibiting p21ras-dependent pathways involved in mitogenesis (Furet et al., 1998; Smithgall, 1995).”
BackgroundFukazawa, T., Reedquist, K. A., Panchamoorthy, G., Soltoff, S., Trub, T., Druker, B., Cantley, L., Shoelson, S. E., & Band, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20177 · Cited by 87
In vitro protein kinase C phosphorylation sites of placental lipocortin
Schlaepfer, D. D., & Haigler, H. T. (1988) · Biochemistry · doi:10.1021/bi00412a008 · Cited by 84 · cited 1×
“…substrate for protein kinase C, which phosphorylates the residues Thr24, Ser27 and Ser28 equally in vitro (Summers & Creutz, 1985; Schlaepfer & Haigler, 1988), and for PTK. LC1 is a low (50 nM) km substrate for the EGF-R in A431 cells (Pepinsky & Sinclair, 1986) and in ®broblasts and is also…”
BackgroundStructure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 Domain
Furet, P., Gay, B., Caravatti, G., Garcı́a-Echeverrı́a, C., Rahuel, J., Schoepfer, J. G., & Fretz, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980159a · Cited by 83 · cited 1×
“Blocking the interaction between Tyr-phosphorylated PTK receptors and Grb2 is considered by some to be an attractive strategy for inhibiting p21ras-dependent pathways involved in mitogenesis (Furet et al., 1998; Smithgall, 1995).”
BackgroundSkouteris, G. G., & Schröder, C. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27266 · Cited by 79 · cited 1×
“Skouteris & Schroder (1996) investigated the signal transduction events following the stimulation of A549 cells with hepatocyte growth factor (HGF).”
BackgroundLipocortin-1 and the control of arachidonic acid release in cell signalling
Croxtall, J. D., Choudhury, Q., Tokumoto, H., & Flower, R. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00156-t · Cited by 78 · cited 2×
“Using the A549 human adenocarcinoma cell line we have shown that epidermal growth factor (EGF) can rapidly activate cPLA2 and AA release by a pertussis toxin-sensitive mechanism (Croxtall et al., 1995; 1996).”
BackgroundMethodSelf-citationLipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver.
Karasik, A., Pepinsky, R. B., Shoelson, S. E., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37866-9 · Cited by 77 · cited 4×
“…to other members of the annexin family, we may perhaps anticipate that LC2, as a substrate for pp60v-src oncogene kinases (Radke & Martin, 1979) as well as the insulin receptor kinase (Karasik et al., 1988), will have an analogous e ect on other src-dependent signalling pathways within the cell.”
BackgroundInfluentialBuckingham, J. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15360.x · Cited by 72 · cited 1×
“Similarly, there is considerable evidence for a rapid feedback e ect of glucocorticoids on the anterior pituitary gland that is clearly distinguished from their longer term actions (Buckingham, 1996).”
BackgroundPhosphorylation of a chromaffin granule-binding protein by protein kinase C.
Summers, T. A., & Creutz, C. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89573-4 · Cited by 71 · cited 1×
“…long as 3 h. LC1 is a well characterized substrate for protein kinase C, which phosphorylates the residues Thr24, Ser27 and Ser28 equally in vitro (Summers & Creutz, 1985; Schlaepfer & Haigler, 1988), and for PTK. LC1 is a low (50 nM) km substrate for the EGF-R in A431 cells (Pepinsky & Sinclair,…”
BackgroundLipocortin 1 and the control of cPLA2 activity in A549 cells
Croxtall, J. D., Choudhury, Q., Newman, S. P., & Flower, R. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02442-5 · Cited by 62 · cited 4×
“Using the A549 human adenocarcinoma cell line we have shown that epidermal growth factor (EGF) can rapidly activate cPLA2 and AA release by a pertussis toxin-sensitive mechanism (Croxtall et al., 1995; 1996).”
BackgroundMethodSelf-citationTumlin, J. A., Lea, J. P., Swanson, C. E., Smith, C. L., Edge, S. S., & Someren, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119278 · Cited by 60 · cited 1×
“However, other recent studies con®rm the importance of the GR per se in transduction of the glucocorticoid e ect on phosphatase activity which are transcription-independent in some cells (Tumlin et al., 1997).”
Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats
Vishwanath, B. S. (1992) · Endocrinology · doi:10.1210/en.130.2.585 · Cited by 56 · cited 1×
“Vishwanath et al. (1992) observed that phospholipase A2 levels were inversely related to intracellular LC1 levels in adrenalectomized animals, thus providing presumptive evidence that this is indeed the case.”
BackgroundEvidence for specific annexin I-binding proteins on human monocytes
Goulding, N. J., Pan, L., Wardwell, K., GUYRE, V. C., & Guyre, P. M. (1996) · Biochemical Journal · doi:10.1042/bj3160593 · Cited by 52 · cited 1×
“Indeed, the existence of such proteinaceous LC1 binding sites in the membrane has been repeatedly observed (Goulding et al., 1996).”
BackgroundU937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity
Solito, E., Raguenes‐Nicol, C., De Coupade, C., Bisagni‐Faure, A., & Russo‐Marie, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701991 · Cited by 48 · cited 1×
“(Solito et al. (1998), using U937 cells stably transfected with LC1 sense and antisense, also observed an increase in intracellular PLA2 activity in cells bearing the antisense construct.”
BackgroundCroxtall, J. D., Waheed, S., Choudhury, Q., Anand, R., & Flower, R. J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540124 · Cited by 44 · cited 2×
“A scrambled LC113 ± 25 peptide control was without e ect, as was the peptide LC11± 12, which we have previously shown to be inactive in this system (Croxtall et al., 1993; 1995; 1996).”
BackgroundMethodSelf-citationPostoperative acute adrenal failure caused by transient corticotropin deficiency.
Merry, W. H., Caplan, R. H., Wickus, G. G., Reynertson, R. H., Kisken, W. A., Cogbill, T. H., & Landercasper, J. (1994) · PubMed · Cited by 38
Croxtall, J. D., & Flower, R. J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90458-8 · Cited by 38 · cited 1×
“Transient transfection of A549 cells with antisense LC1 cDNA oligonucleotides blocked the de novo synthesis of LC1, increased the amount of prostaglandins and AA released and lead to an increase in cell growth (Croxtall & Flower, 1994).”
BackgroundSelf-citationCroxtall, J. D., Choudhury, Q., & Flower, R. J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701679 · Cited by 36 · cited 7×
“…on cPLA2 activity and AA release are mediated via the protein lipocortin 1 (LC1, annexin 1) and in particular, we have demonstrated the importance of the N-terminal domain sequence containing the pharmacophore glutamate-glutamineglutamate-tyrosine-valine (EQEYV) (Croxtall et al., 1998).”
BackgroundSelf-citationAnnexin I as a Potential Inhibitor of Insulin Receptor Protein Tyrosine Kinase
Melki, V., Hullin, F., Mazarguil, H., Fauvel, J., Ragab-Thomas, J. M. F., & Chap, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2255 · Cited by 19 · cited 1×
“This was also apparently mediated through the N-terminal domain of LC1, as a peptide containing residues 16 ± 30 mimicked the e ect (Melki et al., 1994).”
Background
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“When liberated from the GR complex, c-Src activates multiple kinase cascades that lead to the phosphorylation of annexin 1, inhibition of cytosolic phospholipase A2 activity, and impaired release of arachidonic acid (46, 47).”
BackgroundPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
“[181] Natural Tr Additionally, a specific nongenomic mechanism has cells express membrane-bound TGFβ that can delivbeen suggested for suppression of cPLA2 ac- er signals to target cells via a contact-dependent tivity.[136] As a consequence, the production of process.”
BackgroundInfluentialShaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.017 · Cited by 715
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Genomic and nongenomic effects of glucocorticoids
Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0898 · Cited by 594
“Some of the observed anti-inflammatory and immunosuppressive effects, however, occur too fast to be explained by this genomic mode of action”
Background
Metadata
- Authors
- Croxtall, J. D., Choudhury, Q., & Flower, R. J.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Croxtall, Jamie D
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 130
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572055
- OpenAlex
- W2076179697
- Cited by
- 332
- References
- 42
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 17
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, dexamethasone, epidermal growth factor receptor, Grb2, p21ras, Raf, ERK signaling, cytosolic phospholipase A2, arachidonic acid release, annexin A1, glucocorticoid receptor, receptor tyrosine kinase signaling, A549 cells
- MeSH terms
- Binding, Competitive, Dexamethasone, Enzyme Activation, Glucocorticoids, Humans, Phospholipases A, Phosphorylation, Protein Conformation, Proteins, Receptors, Glucocorticoid, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Annexin A1, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.